PRESS RELEASES [ See Dengue in the News ]

 

Arbovax Closing In On Vaccine for Chikungunya
RALEIGH, N.C., June 19, 2014 – Arbovax, Inc., a clinical stage biotechnology company, has successfully demonstrated in an animal model the efficacy of its vaccine technology for the treatment of Chikungunya,..
-------------------------------------------------------------------------------------------------------------
Arbovax moves ahead with phase 1 human trials of Dengue vaccine
Following a pre-IND submission to the US FDA, Arbovax in now moving forward with preparations for a phase 1 human trial of their tetravalent dengue vaccine
-------------------------------------------------------------------------------------------------------------
Arbovax Completes Successful Pre-Clinical Trial of Tetravalent Dengue Vaccine
Arbovax Completes Successful Pre-Clinical Trial of Tetravalent Dengue Vaccine Successful Pre-Clinical Tests Support Vaccine Platform, New Injection Protocol Raleigh N.C., March 18,..
-------------------------------------------------------------------------------------------------------------
Arbovax to present at World Vaccine Congress Lyon
Arbovax, Inc. to speak at 13 th World Vaccine Congress, Lyon France   Arbovax, a Bio-technology Company based in Raleigh, NC is scheduled to present their one shot vaccine platform technology at the World Vaccine Congress in Lyon 10 th to the 12 th Octobe..
-------------------------------------------------------------------------------------------------------------
One-shot Dengue Fever Vaccine Moves Closer to Reality
In the last decade Dengue Fever has reemerged as a major health threat, not just in the Far East, but in the Americas. According the World Health Organization, two-fifths of the world’s population is at risk,..
-------------------------------------------------------------------------------------------------------------
Arbovax Completes Primate Trials
Arbovax Passes Significant Milestone in the Development of a Vaccine against Dengue Fever   Novel Approach Yields Promising Results in Primate Trials   October 12,..
-------------------------------------------------------------------------------------------------------------
Arbovax, Inc. To start pre-clinical Dengue vaccine trials
Arbovax, Inc. To start pre-clinical Dengue vaccine trials   RALEIGH, N.C., 21 April 2010 — Arbovax, an early-stage company developing vaccines against insect-borne diseases,..
-------------------------------------------------------------------------------------------------------------

 



    Home    Our Technology    Development Pipeline    News & Articles    About Us    Contact Us     Dengue Fever

Arbovax.com © 2014. All rights reserved | Web Site developed by
eCaribbean Ltd